Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1993 Dec;80(4):652–653.

Serum measurements of soluble CD23 in HIV infection.

A S Bansal 1, R S Pumphrey 1, B K Mandal 1, S H Khoo 1, P B Wilson 1
PMCID: PMC1422255  PMID: 7905861

Abstract

A gradual reduction in cell-mediated immunity is thought to occur with the progression of human immunodeficiency virus (HIV) infection. This suggests a selective attrition of the Th1 subset. The regulation of the soluble form of the low-affinity receptor for IgE (sCD23) by the opposing actions of interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) allows the assessment of the overall balance of Th1 to Th2 activity in a given disease. In order to investigate this further we employed an enhanced chemiluminescent ELISA to analyse serum levels of sCD23 in male subjects with and without HIV infection. Serum levels of sCD23 were similar in 34 HIV seronegative homosexuals, 39 homosexuals with asymptomatic HIV infection, 27 homosexuals with acquired immune deficiency syndrome (AIDS) and 20 healthy controls. This suggests that HIV has no predilection for either the Th1 or Th2 subsets of CD4 T cells.

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bansal A. S., Ollier W., Marsh M. N., Pumphrey R. S., Wilson P. B. Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity. Immunology. 1993 Jun;79(2):285–289. [PMC free article] [PubMed] [Google Scholar]
  2. Bansal A., Roberts T., Hay E. M., Kay R., Pumphrey R. S., Wilson P. B. Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus. Clin Exp Immunol. 1992 Sep;89(3):452–455. doi: 10.1111/j.1365-2249.1992.tb06979.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  4. Embretson J., Zupancic M., Ribas J. L., Burke A., Racz P., Tenner-Racz K., Haase A. T. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature. 1993 Mar 25;362(6418):359–362. doi: 10.1038/362359a0. [DOI] [PubMed] [Google Scholar]
  5. Gordon J. CD23 and B cell activation. Clin Exp Allergy. 1992 Feb;22(2):199–204. doi: 10.1111/j.1365-2222.1992.tb03073.x. [DOI] [PubMed] [Google Scholar]
  6. Maggi E., Parronchi P., Manetti R., Simonelli C., Piccinni M. P., Rugiu F. S., De Carli M., Ricci M., Romagnani S. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol. 1992 Apr 1;148(7):2142–2147. [PubMed] [Google Scholar]
  7. Pantaleo G., Graziosi C., Demarest J. F., Butini L., Montroni M., Fox C. H., Orenstein J. M., Kotler D. P., Fauci A. S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature. 1993 Mar 25;362(6418):355–358. doi: 10.1038/362355a0. [DOI] [PubMed] [Google Scholar]
  8. Pinching A. J., Nye K. E. Defective signal transduction--a common pathway for cellular dysfunction in HIV infection? Immunol Today. 1990 Jul;11(7):256–259. doi: 10.1016/0167-5699(90)90100-n. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES